However, the CM-DOP treatment reversed the effects of N-cadherin and Vimentin, as well as increased the E-cadherin expression in AGS and HGC-27 cancer cells, especially in H-DOP (Figure 5B). This evidence concerns the gene CDH2 and cancer.